AFQ056

mavoglurant · Novartis

Drug timelines are a Plus or Pro feature.

18 regulatory and trial events tracked for AFQ056, covering 2007-06-22 to 2023-10-10. Get the full timeline:

Most recent: Clinical Trial Update: AFQ056 for Language Learning in Children With FXS [Phase 2]